Notifications

No notifications to display.

Check back here for the latest on your quotes, orders, and accounts.

CTC Isolation and Analysis

CTC Isolation and Analysis: A Gateway to Precision Oncology

CTCs offer a non-invasive window into cancer biology. Isolated from blood samples and other biofluids, these rare cells provide critical insights into metastasis, therapeutic resistance, and tumor evolution. 

However, their rarity—often as few as one in a billion blood cells—makes CTC isolation and analysis a technical challenge. This is where Bio-Rad’s innovative tools assist scientists the most.

Start a Conversation with a Specialist

  • icon of light bulb

    Did you know?

    In 1869, Australian physician Thomas Ashworth first observed CTCs in a cancer patient's blood, introducing the concept of tumor-derived cells traveling through the bloodstream.

The Challenges of CTC Research

 

 

  • Inefficient CTC Isolation

    Extracting CTCs from billions of blood cells while maintaining their viability and integrity is a critical bottleneck. Conventional methods like density gradient centrifugation and negative selection are time-consuming and often fall short, leading to sample loss or contamination.

  • Low-Resolution CTC Analysis

    CTC analysis at the molecular level uncovers critical insights into cancer progression, metastasis, and resistance, but their rarity demands advanced tools to generate reliable, high-resolution data.

  • Consistency and Reproducibility

    CTC workflows must produce consistent results to support translational research for clinical applications. Variability and workflow inefficiencies can hinder progress toward meaningful discoveries.

 

Image
Bulletin-3709 thumbnail

Leveraging Microfluidics for CTC and CTC Cluster Capture, Enrichment, and Enumeration

Discover an efficient sized-based isolation solution with the Genesis Platform. Celselect Slides™ capture single and clustered CTCs, filtering out smaller blood components like WBCs, RBCs, and platelets while being gentle enough to recover viable, living cells for proliferation and culturing workflows. 

Genesis System: The Heart of Systematic CTC Analysis

Single-Cell Sequencing Solutions

Unlock the full potential of your CTC isolation and analysis workflows by incorporating the ddSEQ Single Cell Isolator and ddSEQ library prep kits. These tools empower you with high-resolution data to uncover the critical insights hidden within the transcriptome and epigenome of these rare cells.

Image
ddseq-single-cell-isolator

ddSEQ Single Cell Isolator

Study the transcriptome and epigenome of CTCs isolated with Genesis. This space-efficient instrument partitions individual CTCs captured with the Genesis System for downstream single-cell workflows, including 3’ scRNA-seq or scATAC-seq.

ddSEQ Single-Cell 3’ RNA-seq Kit

  • Identify biomarkers and gene expression patterns with high-quality transcriptional profiling.
  • Pinpoint pathways driving tumor progression and uncover therapeutic targets.
  • Maximize your research potential with cost-effective transcriptional landscape analyses.

ddSEQ Single-Cell ATAC-seq Kit

  • Explore chromatin accessibility to uncover epigenetic mechanisms behind metastasis and therapy resistance.
  • Reveal regulatory networks shaping cancer progression.
  • Drive breakthroughs in epigenetic-based translational research and treatment development.

Droplet Digital™ PCR (ddPCR) Solutions

Enhance your analysis of CTCs recovered with the Genesis System using ddPCR and PrimePCR™ Assays, enabling absolute quantification of biomarkers, rare mutations, and gene expression changes. This high-sensitivity approach ensures reproducible and high-resolution data for cancer research and translational applications.

Image
qx600 ddpcr q185

QX600™ ddPCR System

Analyze and quantify rare nucleic acid events, transcript levels, and biomarkers  from CTCs with ultra-high sensitivity, precision, and advanced multiplexing capabilities. This innovative technology delivers reproducible results, even from minimal sample input.

ddPCR Technology

  • Identify and quantify rare mutations with unparalleled sensitivity and precision.
  • Detect molecular residual disease (MRD) and therapy resistance markers with rapid turnaround time.
  • Enhance liquid biopsy workflows with absolute mutation quantification.

PrimePCR™ Assays on ddPCR

  • Precisely quantify single nucleotide variants and actionable mutations.
  • Streamline biomarker interrogation with pre-designed, optimized gene expression assays.
  • Advance targeted therapy research with reproducible, high-throughput ddPCR workflows.

Shaping the Future of Liquid Biopsy Research

Transform your translational research with advanced liquid biopsy workflows. Bio-Rad’s ddPCR technology provides sensitivity for ctDNA and CTC analysis, uncovering actionable insights into disease states and therapy efficacy.

Hear What Expert ddPCR Users are Saying

Flow Cytometry and Antibody Solutions

Drive your research forward by coupling the Genesis platform, ZE5 Cell Analyzer, validated antibodies, and StarBright™ Dyes for high-throughput, multiparametric flow cytometry for CTC characterization, immune profiling, and biomarker detection.

Image
ZE5 Cell Analyzer

ZE5™ Cell Analyzer

Simplify your workflows with an automated flow cytometer featuring five lasers, 30 parameters, and a flexible sample loader. This device enables ultra-sensitive, multiparametric immune profiling of CTCs with unparalleled speed and accuracy.

Flow Cytometry with ZE5

  • Detect and analyze rare CTC populations with ultra-sensitive, high-throughput flow cytometry.
  • Gain multiparametric insights into immune cell interactions with precision and reproducibility.
  • Automate and accelerate high-content CTC research with intuitive workflow integration.

Validated Antibodies & StarBright™ Dyes

  • Identify key CTC markers with highly specific, flow cytometry-optimized antibodies.
  • Streamline immune profiling and functional studies with StarBright Dye conjugated antibodies.
  • Ensure reproducible, high-sensitivity detection with rigorously validated reagents.

Establish Dynamic and Reproducible Workflows

The Genesis Platform enables the isolation of rare CTCs with unmatched sensitivity, yielding consistent, high-quality results. When paired with our ddSEQ, ddPCR, and flow cytometry solutions, it minimizes variability, ensures reproducible performance across projects, and is flexible for sample input. These tools empower you to adapt effortlessly, meeting the evolving demands of your downstream workflows.

Explore the Genesis Platform

Ready to Elevate Your Research?

Start a Conversation with a Specialist

Featured Resources

Explore Peer-Reviewed Research Empowered by Bio-Rad Solutions

Explore Additional Oncology Solutions

Tumor Profiling

Optimize tumor profiling with advanced molecular tools. Detect rare mutations, analyze gene expression, and uncover biomarkers with confidence and precision.

Biomarker Detection

Transform biomarker research with ddPCR. Identify key mutations, track treatment response, and drive breakthroughs in precision medicine.

ctDNA Analysis

Enhance your oncology research with ddPCR for ctDNA analysis. Detect rare mutations, track MRD, and monitor recurrence with unmatched sensitivity and accuracy.

CML Monitoring

Simplify CML monitoring with ddPCR technology. Achieve ultra-sensitive BCR-ABL detection, streamlined workflows, and reproducible results across labs.